In silico comparison of gene expression levels in ten human tumor types reveals candidate genes associated with carcinogenesis

Cytogenetic and Genome Research

Volumn 112, Issue 1-2, 2006, Pages 53-59

  Chen, S ^a   Zhu, B ^b   Yu, L ^a  

^a FUDAN UNIVERSITY   (China)

^b NATIONAL UNIVERSITY OF DEFENSE TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; CARCINOGENESIS; CLUSTER ANALYSIS; COMPUTER MODEL; DATA ANALYSIS; DATA BASE; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UNINDEXED SEQUENCE; UPREGULATION;

GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; MULTIGENE FAMILY; NEOPLASMS;

EID: 27644535886     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087513     Document Type: Article

References (25)

1. Chung J, Bachelder RE, Lipscomb EA, Shaw LM, Mercurio AM: Integrin (alpha 6 beta 4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. J Cell Biol 158:165-174 (2002).
2. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP: Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285:245-248 (1999).
3. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100:57-70 (2000).
4. Ito Y, Yoshida H, Nakano K, Kobayashi K, Yokozawa T, Hirai K, Matsuzuka F, Matsuura N, Kuma K, Miyauchi A: Expression of p57/Kip2 protein in normal and neoplastic thyroid tissues. Int J Mol Med 9:373-376 (2002).
5. Kikuchi T, Toyota M, Itoh F, Suzuki H, Obata T, Yamamoto H, Kakiuchi H, Kusano M, Issa JP, Tokino T, Imai K: Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors. Oncogene 21:2741-2749 (2002).
6. Leerkes MR, Caballero OL, Mackay A, Torloni H, O'Hare MJ, Simpson AJ, de Souza SJ: In silico comparison of the transcriptome derived from purified normal breast cells and breast tumor cell lines reveals candidate upregulated genes in breast tumor cells. Genomics 79:257-265 (2002).
7. Mahtabifard A, Merritt RE, Yamada RE, Crystal RG, Korst RJ: In vivo gene transfer of pigment epithelium-derived factor inhibits tumor growth in syngeneic murine models of thoracic malignancies. J Thorac Cardiovasc Surg 126:28-38 (2003).
8. Mason MD, Davies G, Jiang WG: Cell adhesion molecules and adhesion abnormalities in prostate cancer. Crit Rev Oncol Hematol 41:11-28 (2002).
9. Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ: p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9:650-662 (1995).
10. Mei R, Galipeau PC, Prass C, Berno A, Ghandour G, Patil N, Wolff RK, Chee MS, Reid BJ, Lochhart DJ: Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res 10:1126-1137 (2000).
11. Miyagishi D, Ohno-Matsui K, Amagasa T, Morita I: Regulation of the expression of pigment epithelium-derived factor, an anti-angiogenic factor in human oral squamous cell carcinoma cell lines. Cancer Lett 196:77-85 (2003).
12. Modugno M, Tagliabue E, Ardini E, Berno V, Galmoz-zi E, De Bortoli M, Castronovo V, Menard S: p53-dependent downregulation of metastasis-associated laminin receptor. Oncogene 21:7478-7487 (2002).
13. Peterson LE: CLUSFAVOR 5.0: hierarchical cluster and principal-component analysis of microarray-based transcriptional profiles. Genome Biol 3:SOFTWARE0002 (2002).
14. Ricky WJ, Astrid AR, Scott WL: Apoptosis: A link between cancer genetics and chemotherapy. Cell 108:153-164 (2002).
15. Scheurle D, DeYoung MP, Binninger DM, Page H, Jahanzeb M, Narayanan R: Cancer gene discovery using digital differential display. Cancer Res 60:4037-4043 (2000).
16. Schluter C, Duchrow M, Wohlenberg C, Becker MH, Key G, Flad HD, Gerdes J: The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 123:513-522 (1993).
17. Schuler GD, Boguski MS, Stewart EA, Stein LD, Gyapay G, Rice K, White RE, Rodriguez-Tome P, et al: A gene map of the human genome. Science 274:540-546 (1996).
18. Shi Y, Zhai H, Wang X, Wu H, Ning X, Han Y, Zhang D, Xiao B, Wu K, Fan D: Multidrug-resistance-associated protein MGr1-Ag is identical to the human 37-kDa laminin receptor precursor. Cell Mol Life Sci 59:1577-1583 (2002).
19. Sporn MB: The war on cancer. Lancet 347:1377-1381 (1996).
20. Stanton JL, Macgregor AB, Green DPL: Using expressed sequence tag databases to identify ovarian genes of interest. Mol Cell Endocrin 191:11-14 (2002).
21. Takita J, Ishii M, Tsutsumi S, Tanaka Y, Kata K, Toyoda Y, Hanada R, Yamamoto K, Hayashi Y, Aburatani H: Gene expression profiling and identification of novel prognostic marker genes in neuroblastoma. Genes Chrom Cancer 40:120-132 (2004).
22. Tang K, Nie D, Cai Y, Honn KV: The beta4 integrin subunit rescues A431 cells from apoptosis through a PI3K/Akt kinase signaling pathway. Biochem Biophys Res Commun 264:127-132 (1999).
23. Tatusov RL, Koonin EV, Lipman DJ: A genomic perspective on protein families. Science 278:631-637 (1997).
24. Toyama T, Iwase H, Yamashita H, Hara Y, Omoto Y, Sugiura H, Zhang Z, Fujii Y: Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer. Cancer Lett 189:97-102 (2003).
25. Zada AA, Singh SM, Reddy VA, Elsasser A, Meisel A, Haferlach T, Tenen DG, Hiddemann W, Behre G: Downregulation of c-Jun expression and cell cycle regulatory molecules in acute myeloid leukemia cells upon CD44 ligation. Oncogene 22:2296-2308 (2003).